Cargando…

In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models

In the field of orthopaedic surgery, bacterial invasion of implants and the resulting periprosthetic infections are a common and unresolved problem. Antimicrobial susceptibility testing methods help to define the optimal treatment and identify antimicrobial resistance. This review discusses proven g...

Descripción completa

Detalles Bibliográficos
Autores principales: Schumacher, A., Vranken, T., Malhotra, A., Arts, J. J. C., Habibovic, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780537/
https://www.ncbi.nlm.nih.gov/pubmed/28871407
http://dx.doi.org/10.1007/s10096-017-3089-2
_version_ 1783294761795321856
author Schumacher, A.
Vranken, T.
Malhotra, A.
Arts, J. J. C.
Habibovic, P.
author_facet Schumacher, A.
Vranken, T.
Malhotra, A.
Arts, J. J. C.
Habibovic, P.
author_sort Schumacher, A.
collection PubMed
description In the field of orthopaedic surgery, bacterial invasion of implants and the resulting periprosthetic infections are a common and unresolved problem. Antimicrobial susceptibility testing methods help to define the optimal treatment and identify antimicrobial resistance. This review discusses proven gold-standard techniques and recently developed models for antimicrobial susceptibility testing, while also providing a future outlook. Conventional, gold-standard methods, such as broth microdilution, are still widely applied in clinical settings. Although recently developed methods based on microfluidics and microdroplets have shown advantages over conventional methods in terms of testing speed, safety and the potential to provide a deeper insight into resistance mechanisms, extensive validation is required to translate this research to clinical practice. Recent optical and mechanical methods are complex and expensive and, therefore, not immediately clinically applicable. Novel osteoblast infection and tissue models best resemble infections in vivo. However, the integration of biomaterials into these models remains challenging and they require a long tissue culture, making their rapid clinical implementation unlikely. A method applicable for both clinical and research environments is difficult to realise. With a continuous increase in antimicrobial resistance, there is an urgent need for methods that analyse recurrent infections to identify the optimal treatment approaches. [Figure: see text]
format Online
Article
Text
id pubmed-5780537
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-57805372018-02-01 In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models Schumacher, A. Vranken, T. Malhotra, A. Arts, J. J. C. Habibovic, P. Eur J Clin Microbiol Infect Dis Review In the field of orthopaedic surgery, bacterial invasion of implants and the resulting periprosthetic infections are a common and unresolved problem. Antimicrobial susceptibility testing methods help to define the optimal treatment and identify antimicrobial resistance. This review discusses proven gold-standard techniques and recently developed models for antimicrobial susceptibility testing, while also providing a future outlook. Conventional, gold-standard methods, such as broth microdilution, are still widely applied in clinical settings. Although recently developed methods based on microfluidics and microdroplets have shown advantages over conventional methods in terms of testing speed, safety and the potential to provide a deeper insight into resistance mechanisms, extensive validation is required to translate this research to clinical practice. Recent optical and mechanical methods are complex and expensive and, therefore, not immediately clinically applicable. Novel osteoblast infection and tissue models best resemble infections in vivo. However, the integration of biomaterials into these models remains challenging and they require a long tissue culture, making their rapid clinical implementation unlikely. A method applicable for both clinical and research environments is difficult to realise. With a continuous increase in antimicrobial resistance, there is an urgent need for methods that analyse recurrent infections to identify the optimal treatment approaches. [Figure: see text] Springer Berlin Heidelberg 2017-09-04 2018 /pmc/articles/PMC5780537/ /pubmed/28871407 http://dx.doi.org/10.1007/s10096-017-3089-2 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Schumacher, A.
Vranken, T.
Malhotra, A.
Arts, J. J. C.
Habibovic, P.
In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
title In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
title_full In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
title_fullStr In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
title_full_unstemmed In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
title_short In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
title_sort in vitro antimicrobial susceptibility testing methods: agar dilution to 3d tissue-engineered models
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780537/
https://www.ncbi.nlm.nih.gov/pubmed/28871407
http://dx.doi.org/10.1007/s10096-017-3089-2
work_keys_str_mv AT schumachera invitroantimicrobialsusceptibilitytestingmethodsagardilutionto3dtissueengineeredmodels
AT vrankent invitroantimicrobialsusceptibilitytestingmethodsagardilutionto3dtissueengineeredmodels
AT malhotraa invitroantimicrobialsusceptibilitytestingmethodsagardilutionto3dtissueengineeredmodels
AT artsjjc invitroantimicrobialsusceptibilitytestingmethodsagardilutionto3dtissueengineeredmodels
AT habibovicp invitroantimicrobialsusceptibilitytestingmethodsagardilutionto3dtissueengineeredmodels